Analyst Price Target is $8.38
▲ +160.09% Upside Potential
This price target is based on 2 analysts offering 12 month price targets for Medexus Pharmaceuticals in the last 3 months. The average price target is $8.38, with a high forecast of $9.50 and a low forecast of $7.25. The average price target represents a 160.09% upside from the last price of $3.22.
Current Consensus is
The current consensus among 2 contributing investment analysts is to buy stock in Medexus Pharmaceuticals. This rating has held steady since July 2020, when it changed from a Hold consensus rating.